Showing results (951-960 of 6,768) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|February 2, 2013
Telaprevir versus boceprevir in chronic hepatitis C: a meta-analysis of data from phase II and III trialsMugdha Sitole, Matthew Silva, Linda Spooner, et al.Clinical Therapeutics|July 23, 2013
The pharmacokinetics and safety of a fixed-dose combination of acetylsalicylic acid and clopidogrel compared with the concurrent administration of acetylsalicylic acid and clopidogrel in healthy subjects: a randomized, open-label, 2-sequence, 2-period, single-dose crossover studyJin Ah Jung, Tae-Eun Kim, Jung-Ryul Kim, et al.Clinical Therapeutics|July 23, 2013
The role of adiponectin as a compensatory mediator for the primary secretory defect in latent autoimmune diabetes in adultsErifili Hatziagelaki, Vaia Lambadiari, Anastasia Tsiavou, et al.Clinical Therapeutics|July 23, 2013
Effect of food on the pharmacokinetic properties of the oral sarpogrelate hydrochloride controlled-release tablet in healthy male Korean subjectsJin Ah Jung, Jung-Ryul Kim, Tae-Eun Kim, et al.Clinical Therapeutics|July 27, 2013
The bad taste of medicines: overview of basic research on bitter tasteJulie A Mennella, Alan C Spector, Danielle R Reed, et al.Clinical Therapeutics|August 13, 2013
Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertensionHoward Lee, Kee Sik Kim, Shung Chull Chae, et al.Clinical Therapeutics|August 6, 2013
Pharmacokinetic and pharmacodynamic properties of single- and multiple-dose of dapagliflozin, a selective inhibitor of SGLT2, in healthy Chinese subjectsLi Yang, Haiyan Li, Hongmei Li, et al.Clinical Therapeutics|August 6, 2013
Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjectsBrian Zambrowicz, Ike Ogbaa, Kenny Frazier, et al.Clinical Therapeutics|August 7, 2013
The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patientsMichael DavidsonClinical Therapeutics|August 27, 2013
Targeting the unstable plaque in acute coronary syndromesPeter L Thompson, S Mark Nidorf, John EikelboomPageof 677